us-abfm MCQ (SBA): Type 2 Diabetes Therapy

Instant feedback + full explanation. One question, done properly.

ModerateEndocrinologyType 2 Diabetes Therapyus-abfmus-abim

A 60-year-old with T2DM and BMI 41 is on metformin and SGLT2 inhibitor. Atherosclerotic disease present. Which agent provides additional CV benefit and weight loss?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.

us-abfm MCQ: Type 2 Diabetes Therapy — Answer & Explanation | iatroX